Semi-quantitative dopamine transporter standardized uptake value in comparison with conventional specific binding ratio in [123I] FP-CIT single-photon emission computed tomography (DaTscan)

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Neurological Sciences

• Publication date

  2018-05-10

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s10072-018-3437-8PMID 29748936
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Added Value of Combined Semi-Quantitative and Visual [123I]FP-CIT SPECT Analyses for the Diagnosis of Dementia With Lewy Bodies

  2017cited by this paper
• Diagnosis and management of dementia with Lewy bodies

  2017cited by this paper
• Comparison of diagnostic utility of semi-quantitative analysis for DAT-SPECT for distinguishing DLB from AD.

  2017cited by this paper
• Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

  2017cited by this paper
• Combined visual and semi-quantitative assessment of 123I-FP-CIT SPECT for the diagnosis of dopaminergic neurodegenerative diseases

  2017cited by this paper
• Computed-tomography-guided anatomic standardization for quantitative assessment of dopamine transporter SPECT

  2017cited by this paper
• A novel 11C-labeled thymidine analog, [11C]AZT, for tumor imaging by positron emission tomography

  2015cited by this paper
• The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson’s disease or clinically uncertain parkinsonism: a systematic review

  2015cited by this paper
• Absolute SPECT/CT quantification of cerebral uptake of 99mTc-HMPAO for patients with neurocognitive disorders

  2015cited by this paper
• The Role of Functional Dopamine-Transporter SPECT Imaging in Parkinsonian Syndromes, Part 1

  2015cited by this paper
• MDS clinical diagnostic criteria for Parkinson's disease

  2015cited by this paper
• Longitudinal analysis of bone metabolism using SPECT/CT and 99mTc-diphosphono-propanedicarboxylic acid: comparison of visual and quantitative analysis

  2015cited by this paper
• The Role of Functional Dopamine-Transporter SPECT Imaging in Parkinsonian Syndromes, Part 2

  2015cited by this paper
• Measurement of absolute myocardial blood flow in humans using dynamic cardiac SPECT and 99mTc-tetrofosmin: Method and validation

  2015cited by this paper
• Neuroimaging in Parkinson disease: from research setting to clinical practice

  2014cited by this paper
• An Evidence-Based Review of Quantitative SPECT Imaging and Potential Clinical Applications

  2013cited by this paper
• Quantification of 99mTc-DPD concentration in the lumbar spine with SPECT/CT

  2013cited by this paper
• Criteria for the diagnosis of corticobasal degeneration

  2013cited by this paper
• European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis

  2012cited by this paper
• The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration.

  2011cited by this paper
• Absolute quantification in SPECT

  2011cited by this paper
• Quantitative Accuracy of Clinical 99mTc SPECT/CT Using Ordered-Subset Expectation Maximization with 3-Dimensional Resolution Recovery, Attenuation, and Scatter Correction

  2010cited by this paper
• Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: A 3‐year European multicenter study with repeat [123I]FP‐CIT SPECT

  2009cited by this paper
• Second consensus statement on the diagnosis of multiple system atrophy

  2008cited by this paper
• A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies

  2008cited by this paper
• Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy

  2007cited by this paper
• Patients with adult‐onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs)

  2007cited by this paper
• [123I]‐FP/CIT SPECT imaging for distinguishing drug‐induced parkinsonism from Parkinson's disease

  2006cited by this paper
• Psychogenic parkinsonism: A combination of clinical, electrophysiological, and [123I]‐FP‐CIT SPECT scan explorations improves diagnostic accuracy

  2006cited by this paper
• Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio

  2006cited by this paper
• Understanding the standardized uptake value, its methods, and implications for usage.

  2004cited by this paper
• Presynaptic nigro-striatal function in a group of Alzheimer’s disease patients with parkinsonism: evidence from a dopamine transporter imaging study

  2004cited by this paper
• [123I]β‐CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease

  2002cited by this paper
• Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: A longitudinal β‐CIT SPECT study

  2002cited by this paper
• [(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy.

  2001cited by this paper
• [123I]β‐CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy

  2001cited by this paper
• Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]‐FP‐CIT SPECT imaging: The [123I]‐FP‐CIT study group

  2000cited by this paper
• Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group.

  2000cited by this paper
• [123I]β-CIT and SPECT in essential tremor and Parkinson's disease

  1998cited by this paper
• [123I]beta-CIT and SPECT in essential tremor and Parkinson's disease.

  1998cited by this paper
• Human biodistribution and dosimetry of iodine-123-fluoroalkyl analogs of β-CIT

  1997cited by this paper
• Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy.

  1997cited by this paper
• Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters

  1997cited by this paper
• Human biodistribution and dosimetry of iodine-123-fluoroalkyl analogs of beta-CIT.

  1997cited by this paper
• Measurement of the dopaminergic degeneration in Parkinson’s disease with [123I]β-CIT and SPECT

  1997cited by this paper
• Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.

  1988cited by this paper

• [Validation of Changes over Time in Sensitivity Calibrations of SPECT Quantification for Different Radionuclides].

  2025cites this paper
• Symmetric 3D Convolutional Network with Uncertainty Estimation for MRI-Based Striatal DaT-Uptake Assessment in Parkinson’s Disease

  2025cites this paper
• A Symmetric Regressor for MRI-Based Assessment of Striatal Dopamine Transporter Uptake in Parkinson's Disease

  2024cites this paper
• Comparison of the ability of different quantitative indices in 123I-FP-CIT single-photon emission computed tomography to differentiate dopaminergic neurodegenerative disease

  2024influential citation
• A new quantitative index in the diagnosis of Parkinson syndrome by dopamine transporter single-photon emission computed tomography

  2021cites this paper
• [Verification of Image Reconstruction Method and Collimator Suitable for Quantitative Analysis of Striatum in Dopamine Transporter Scintigraphy].

  2020cites this paper